Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Health Equity | 25 | 2024 | 94 | 11.940 |
Why?
|
Healthcare Disparities | 50 | 2024 | 410 | 10.920 |
Why?
|
Diabetes Mellitus | 56 | 2024 | 738 | 9.110 |
Why?
|
Community Health Centers | 25 | 2016 | 115 | 5.490 |
Why?
|
Patient-Centered Care | 16 | 2022 | 207 | 4.630 |
Why?
|
Delivery of Health Care | 21 | 2024 | 434 | 4.360 |
Why?
|
Racism | 6 | 2023 | 89 | 4.280 |
Why?
|
Attitude of Health Personnel | 25 | 2022 | 643 | 3.630 |
Why?
|
Diabetes Mellitus, Type 2 | 27 | 2023 | 1176 | 3.530 |
Why?
|
Quality of Health Care | 21 | 2022 | 385 | 3.480 |
Why?
|
Safety-net Providers | 10 | 2019 | 37 | 3.090 |
Why?
|
Health Status Disparities | 13 | 2024 | 187 | 3.000 |
Why?
|
United States | 91 | 2024 | 6955 | 2.790 |
Why?
|
Humans | 258 | 2024 | 89063 | 2.620 |
Why?
|
Quality Assurance, Health Care | 16 | 2014 | 225 | 2.610 |
Why?
|
Quality Improvement | 18 | 2023 | 447 | 2.600 |
Why?
|
Health Personnel | 7 | 2022 | 212 | 2.460 |
Why?
|
Patient Participation | 9 | 2019 | 224 | 2.220 |
Why?
|
Self Care | 13 | 2019 | 164 | 2.220 |
Why?
|
Health Care Reform | 4 | 2021 | 85 | 2.050 |
Why?
|
Chronic Disease | 14 | 2023 | 948 | 2.040 |
Why?
|
Students, Medical | 4 | 2023 | 418 | 1.970 |
Why?
|
Decision Making | 10 | 2020 | 665 | 1.920 |
Why?
|
Health Policy | 8 | 2023 | 184 | 1.860 |
Why?
|
Primary Health Care | 14 | 2024 | 351 | 1.820 |
Why?
|
Physician-Patient Relations | 13 | 2023 | 625 | 1.820 |
Why?
|
Diabetes Complications | 13 | 2015 | 170 | 1.800 |
Why?
|
Insurance, Health | 10 | 2023 | 159 | 1.750 |
Why?
|
Sexual and Gender Minorities | 6 | 2020 | 205 | 1.690 |
Why?
|
Physicians | 15 | 2016 | 689 | 1.660 |
Why?
|
Religion and Medicine | 10 | 2014 | 124 | 1.660 |
Why?
|
Community Health Services | 7 | 2014 | 82 | 1.660 |
Why?
|
Ambulatory Care Facilities | 6 | 2017 | 111 | 1.640 |
Why?
|
Minority Groups | 8 | 2024 | 144 | 1.640 |
Why?
|
Patient Education as Topic | 17 | 2019 | 359 | 1.550 |
Why?
|
Medicaid | 10 | 2024 | 229 | 1.460 |
Why?
|
Prejudice | 7 | 2021 | 48 | 1.440 |
Why?
|
Health Services Accessibility | 13 | 2021 | 424 | 1.420 |
Why?
|
Heart Failure | 16 | 2024 | 1180 | 1.420 |
Why?
|
Male | 117 | 2024 | 42251 | 1.410 |
Why?
|
Machine Learning | 3 | 2022 | 257 | 1.370 |
Why?
|
Trust | 3 | 2023 | 98 | 1.370 |
Why?
|
Female | 120 | 2024 | 46011 | 1.360 |
Why?
|
Quality Indicators, Health Care | 7 | 2020 | 146 | 1.330 |
Why?
|
Medical Informatics | 2 | 2022 | 49 | 1.320 |
Why?
|
Health Status | 13 | 2017 | 370 | 1.310 |
Why?
|
Cross-Sectional Studies | 29 | 2024 | 1706 | 1.310 |
Why?
|
Health Knowledge, Attitudes, Practice | 11 | 2015 | 531 | 1.280 |
Why?
|
Delivery of Health Care, Integrated | 4 | 2017 | 58 | 1.260 |
Why?
|
Health Promotion | 6 | 2023 | 163 | 1.250 |
Why?
|
Health Care Surveys | 15 | 2017 | 280 | 1.200 |
Why?
|
Health Services Needs and Demand | 4 | 2019 | 103 | 1.190 |
Why?
|
Adult | 70 | 2024 | 26507 | 1.180 |
Why?
|
Aged | 66 | 2023 | 19077 | 1.170 |
Why?
|
Reimbursement, Incentive | 6 | 2018 | 37 | 1.120 |
Why?
|
Chicago | 24 | 2018 | 1423 | 1.120 |
Why?
|
Insurance Coverage | 6 | 2016 | 118 | 1.120 |
Why?
|
Middle Aged | 70 | 2024 | 25863 | 1.090 |
Why?
|
Blood Glucose | 9 | 2021 | 836 | 1.090 |
Why?
|
Burnout, Professional | 4 | 2019 | 100 | 1.070 |
Why?
|
Social Support | 7 | 2023 | 208 | 1.070 |
Why?
|
Population Health | 2 | 2023 | 33 | 1.040 |
Why?
|
Job Satisfaction | 3 | 2019 | 76 | 1.040 |
Why?
|
Socioeconomic Factors | 12 | 2023 | 582 | 1.030 |
Why?
|
Awards and Prizes | 2 | 2024 | 37 | 1.030 |
Why?
|
Residence Characteristics | 7 | 2019 | 200 | 1.020 |
Why?
|
Surveys and Questionnaires | 26 | 2023 | 2612 | 1.020 |
Why?
|
Curriculum | 7 | 2023 | 567 | 0.990 |
Why?
|
Health Expenditures | 4 | 2020 | 91 | 0.990 |
Why?
|
Quality of Life | 12 | 2023 | 1662 | 0.960 |
Why?
|
Program Evaluation | 12 | 2018 | 306 | 0.960 |
Why?
|
Public Health | 3 | 2022 | 137 | 0.950 |
Why?
|
Patient Care Management | 3 | 2010 | 30 | 0.930 |
Why?
|
Morale | 4 | 2019 | 14 | 0.930 |
Why?
|
Internal Medicine | 8 | 2008 | 355 | 0.920 |
Why?
|
Health Services Research | 14 | 2023 | 137 | 0.900 |
Why?
|
Health Behavior | 8 | 2015 | 184 | 0.900 |
Why?
|
Endocrine System Diseases | 2 | 2021 | 23 | 0.900 |
Why?
|
Spirituality | 6 | 2007 | 87 | 0.890 |
Why?
|
Patient Satisfaction | 10 | 2017 | 461 | 0.890 |
Why?
|
Students, Health Occupations | 1 | 2023 | 5 | 0.890 |
Why?
|
Organizational Innovation | 3 | 2019 | 41 | 0.880 |
Why?
|
Language | 2 | 2015 | 154 | 0.870 |
Why?
|
Program Development | 10 | 2017 | 123 | 0.870 |
Why?
|
Drama | 1 | 2022 | 7 | 0.860 |
Why?
|
Education, Medical | 2 | 2023 | 243 | 0.860 |
Why?
|
Renal Dialysis | 2 | 2017 | 335 | 0.840 |
Why?
|
Community Networks | 2 | 2014 | 30 | 0.840 |
Why?
|
Hospitalization | 10 | 2024 | 876 | 0.810 |
Why?
|
Drug Costs | 1 | 2022 | 63 | 0.800 |
Why?
|
Health Plan Implementation | 5 | 2018 | 56 | 0.780 |
Why?
|
Models, Organizational | 5 | 2016 | 47 | 0.780 |
Why?
|
Religion | 4 | 2007 | 88 | 0.770 |
Why?
|
Total Quality Management | 3 | 2010 | 33 | 0.760 |
Why?
|
Algorithms | 5 | 2023 | 1875 | 0.750 |
Why?
|
Ethicists | 1 | 2020 | 20 | 0.750 |
Why?
|
Ethics Consultation | 1 | 2020 | 12 | 0.740 |
Why?
|
Hospitals | 3 | 2023 | 299 | 0.730 |
Why?
|
Patient Care | 1 | 2021 | 102 | 0.730 |
Why?
|
Leadership | 4 | 2023 | 138 | 0.720 |
Why?
|
Hypertension | 7 | 2022 | 741 | 0.710 |
Why?
|
Peer Group | 2 | 2012 | 81 | 0.690 |
Why?
|
Professional-Patient Relations | 4 | 2016 | 54 | 0.690 |
Why?
|
Practice Patterns, Physicians' | 7 | 2015 | 599 | 0.690 |
Why?
|
Palliative Care | 2 | 2020 | 263 | 0.670 |
Why?
|
Teaching | 1 | 2020 | 147 | 0.670 |
Why?
|
Aged, 80 and over | 29 | 2019 | 6777 | 0.660 |
Why?
|
Urban Population | 7 | 2011 | 224 | 0.660 |
Why?
|
Cystic Fibrosis | 1 | 2020 | 115 | 0.660 |
Why?
|
Research Support as Topic | 4 | 2011 | 85 | 0.660 |
Why?
|
Continuity of Patient Care | 2 | 2017 | 172 | 0.650 |
Why?
|
Health Services for the Aged | 3 | 2006 | 32 | 0.630 |
Why?
|
Medically Uninsured | 6 | 2016 | 59 | 0.630 |
Why?
|
Cardiovascular Diseases | 7 | 2021 | 705 | 0.600 |
Why?
|
Exercise | 7 | 2015 | 322 | 0.580 |
Why?
|
Adolescent | 22 | 2022 | 9237 | 0.580 |
Why?
|
Cooperative Behavior | 7 | 2018 | 179 | 0.580 |
Why?
|
Catholicism | 3 | 2015 | 43 | 0.580 |
Why?
|
Social Justice | 3 | 2020 | 54 | 0.580 |
Why?
|
Reimbursement Mechanisms | 1 | 2017 | 41 | 0.580 |
Why?
|
Midwestern United States | 8 | 2014 | 82 | 0.580 |
Why?
|
Poverty | 2 | 2017 | 180 | 0.570 |
Why?
|
Qualitative Research | 9 | 2023 | 291 | 0.560 |
Why?
|
Poverty Areas | 5 | 2020 | 37 | 0.550 |
Why?
|
Vulnerable Populations | 5 | 2014 | 83 | 0.550 |
Why?
|
Electronic Health Records | 2 | 2022 | 341 | 0.550 |
Why?
|
Organ Transplantation | 1 | 2020 | 275 | 0.550 |
Why?
|
Social Environment | 1 | 2017 | 187 | 0.550 |
Why?
|
Health | 2 | 2007 | 29 | 0.540 |
Why?
|
Bisexuality | 1 | 2016 | 32 | 0.540 |
Why?
|
Health Care Costs | 5 | 2012 | 235 | 0.540 |
Why?
|
Specialization | 3 | 2008 | 65 | 0.530 |
Why?
|
Cultural Competency | 2 | 2022 | 21 | 0.520 |
Why?
|
Activities of Daily Living | 6 | 2005 | 207 | 0.520 |
Why?
|
Emergency Service, Hospital | 6 | 2024 | 521 | 0.520 |
Why?
|
Kidney Failure, Chronic | 2 | 2017 | 413 | 0.520 |
Why?
|
Tissue and Organ Procurement | 1 | 2020 | 345 | 0.510 |
Why?
|
Renal Insufficiency, Chronic | 2 | 2016 | 219 | 0.510 |
Why?
|
Precision Medicine | 2 | 2016 | 410 | 0.500 |
Why?
|
Arthroplasty, Replacement | 1 | 2015 | 37 | 0.490 |
Why?
|
Medicare Part C | 1 | 2014 | 7 | 0.490 |
Why?
|
Motivation | 6 | 2018 | 296 | 0.490 |
Why?
|
Interviews as Topic | 10 | 2019 | 334 | 0.480 |
Why?
|
Patient Care Team | 5 | 2019 | 283 | 0.480 |
Why?
|
Documentation | 1 | 2015 | 103 | 0.480 |
Why?
|
Drug Utilization Review | 3 | 1999 | 14 | 0.480 |
Why?
|
Focus Groups | 6 | 2019 | 170 | 0.480 |
Why?
|
Communication | 6 | 2023 | 457 | 0.460 |
Why?
|
Mexican Americans | 1 | 2014 | 67 | 0.460 |
Why?
|
Attitude to Health | 6 | 2016 | 222 | 0.450 |
Why?
|
Obesity | 6 | 2019 | 966 | 0.440 |
Why?
|
Cardiology | 4 | 2009 | 115 | 0.440 |
Why?
|
Cultural Diversity | 5 | 2021 | 57 | 0.430 |
Why?
|
Young Adult | 13 | 2019 | 6288 | 0.430 |
Why?
|
Health Facility Administrators | 5 | 2015 | 15 | 0.410 |
Why?
|
Databases, Factual | 1 | 2016 | 850 | 0.410 |
Why?
|
Logistic Models | 11 | 2014 | 1212 | 0.410 |
Why?
|
Smoking Cessation | 1 | 2015 | 252 | 0.410 |
Why?
|
Academic Medical Centers | 4 | 2018 | 385 | 0.410 |
Why?
|
Referral and Consultation | 4 | 2011 | 341 | 0.410 |
Why?
|
Preventive Health Services | 3 | 2022 | 39 | 0.400 |
Why?
|
Patient Preference | 1 | 2012 | 108 | 0.390 |
Why?
|
Bias | 2 | 2022 | 131 | 0.380 |
Why?
|
Medical Errors | 2 | 2009 | 117 | 0.380 |
Why?
|
Medicare | 5 | 2020 | 423 | 0.380 |
Why?
|
Risk Reduction Behavior | 3 | 2008 | 96 | 0.380 |
Why?
|
Reproducibility of Results | 8 | 2022 | 2752 | 0.380 |
Why?
|
Geriatrics | 3 | 2003 | 66 | 0.370 |
Why?
|
Overweight | 2 | 2011 | 119 | 0.370 |
Why?
|
Education, Medical, Undergraduate | 2 | 2016 | 178 | 0.370 |
Why?
|
Medical Informatics Applications | 1 | 2010 | 9 | 0.370 |
Why?
|
Family Health | 1 | 2011 | 162 | 0.370 |
Why?
|
Child Health Services | 1 | 2011 | 48 | 0.370 |
Why?
|
Multivariate Analysis | 10 | 2017 | 988 | 0.360 |
Why?
|
Managed Care Programs | 2 | 2023 | 42 | 0.360 |
Why?
|
Behavior Therapy | 1 | 2011 | 84 | 0.360 |
Why?
|
Ethics, Medical | 3 | 2007 | 307 | 0.350 |
Why?
|
School Admission Criteria | 1 | 2010 | 23 | 0.350 |
Why?
|
Sexual Behavior | 2 | 2020 | 309 | 0.330 |
Why?
|
Motor Activity | 2 | 2008 | 327 | 0.330 |
Why?
|
Emigrants and Immigrants | 1 | 2009 | 43 | 0.330 |
Why?
|
Government Regulation | 1 | 2009 | 49 | 0.330 |
Why?
|
Safety Management | 1 | 2009 | 56 | 0.320 |
Why?
|
Angiotensin-Converting Enzyme Inhibitors | 3 | 1997 | 91 | 0.320 |
Why?
|
Emergency Medical Services | 2 | 2003 | 238 | 0.320 |
Why?
|
Life Style | 3 | 2006 | 172 | 0.320 |
Why?
|
Prevalence | 7 | 2020 | 1240 | 0.320 |
Why?
|
Safety | 1 | 2009 | 149 | 0.310 |
Why?
|
Social Identification | 1 | 2008 | 26 | 0.310 |
Why?
|
Child | 12 | 2024 | 7149 | 0.310 |
Why?
|
Directive Counseling | 1 | 2008 | 35 | 0.310 |
Why?
|
Costs and Cost Analysis | 3 | 2022 | 153 | 0.310 |
Why?
|
Comorbidity | 9 | 2015 | 948 | 0.310 |
Why?
|
Health Facilities | 3 | 2021 | 36 | 0.300 |
Why?
|
Medicine | 3 | 2008 | 91 | 0.300 |
Why?
|
Quality-Adjusted Life Years | 2 | 2007 | 142 | 0.300 |
Why?
|
Diabetes Mellitus, Type 1 | 2 | 2012 | 559 | 0.300 |
Why?
|
Evidence-Based Practice | 2 | 2018 | 47 | 0.300 |
Why?
|
Feedback | 2 | 2020 | 134 | 0.300 |
Why?
|
Professional Practice Location | 1 | 2007 | 6 | 0.300 |
Why?
|
Research | 4 | 2005 | 252 | 0.290 |
Why?
|
Professional Role | 1 | 2007 | 41 | 0.290 |
Why?
|
Myocardial Infarction | 3 | 2003 | 373 | 0.290 |
Why?
|
Foundations | 3 | 2012 | 15 | 0.290 |
Why?
|
Prospective Studies | 15 | 2015 | 4273 | 0.290 |
Why?
|
Models, Psychological | 3 | 2008 | 158 | 0.290 |
Why?
|
Community-Based Participatory Research | 3 | 2019 | 36 | 0.290 |
Why?
|
Bariatric Surgery | 2 | 2007 | 195 | 0.290 |
Why?
|
Social Determinants of Health | 4 | 2022 | 95 | 0.290 |
Why?
|
Health Communication | 2 | 2017 | 13 | 0.290 |
Why?
|
Parents | 2 | 2022 | 285 | 0.290 |
Why?
|
Models, Theoretical | 3 | 2017 | 491 | 0.280 |
Why?
|
Disease Management | 3 | 2019 | 329 | 0.280 |
Why?
|
Patient Compliance | 4 | 2020 | 230 | 0.280 |
Why?
|
Maryland | 2 | 2023 | 42 | 0.270 |
Why?
|
Cohort Studies | 7 | 2023 | 2863 | 0.270 |
Why?
|
Pandemics | 2 | 2023 | 771 | 0.270 |
Why?
|
Diet, Reducing | 1 | 2006 | 29 | 0.270 |
Why?
|
Primary Prevention | 2 | 2006 | 81 | 0.260 |
Why?
|
Hyperlipidemias | 1 | 2006 | 92 | 0.260 |
Why?
|
Pilot Projects | 5 | 2016 | 865 | 0.260 |
Why?
|
Chi-Square Distribution | 4 | 2014 | 360 | 0.250 |
Why?
|
Hawaii | 2 | 2023 | 25 | 0.250 |
Why?
|
Guidelines as Topic | 1 | 2006 | 160 | 0.250 |
Why?
|
Practice Management, Medical | 2 | 2014 | 23 | 0.250 |
Why?
|
Self-Assessment | 1 | 2005 | 47 | 0.250 |
Why?
|
Data Collection | 5 | 2012 | 375 | 0.250 |
Why?
|
Mortality | 3 | 2016 | 149 | 0.240 |
Why?
|
Goals | 1 | 2005 | 67 | 0.240 |
Why?
|
Decision Support Techniques | 2 | 2008 | 167 | 0.240 |
Why?
|
Interprofessional Relations | 2 | 2020 | 122 | 0.230 |
Why?
|
Health Facility Closure | 1 | 2024 | 7 | 0.230 |
Why?
|
Geriatric Assessment | 3 | 2013 | 182 | 0.230 |
Why?
|
Morals | 2 | 2020 | 94 | 0.230 |
Why?
|
Cost-Benefit Analysis | 6 | 2010 | 461 | 0.230 |
Why?
|
Obesity, Morbid | 1 | 2007 | 233 | 0.230 |
Why?
|
Family Practice | 3 | 2000 | 82 | 0.230 |
Why?
|
Academies and Institutes | 1 | 2023 | 32 | 0.230 |
Why?
|
Depression | 3 | 2021 | 503 | 0.230 |
Why?
|
Needs Assessment | 3 | 2002 | 157 | 0.230 |
Why?
|
Interinstitutional Relations | 3 | 2018 | 29 | 0.230 |
Why?
|
Propensity Score | 1 | 2024 | 147 | 0.220 |
Why?
|
Choice Behavior | 1 | 2005 | 160 | 0.220 |
Why?
|
Drug Prescriptions | 1 | 2005 | 144 | 0.220 |
Why?
|
Osteoporosis, Postmenopausal | 1 | 2003 | 33 | 0.220 |
Why?
|
Rheumatoid Nodule | 1 | 2003 | 1 | 0.220 |
Why?
|
Aging | 1 | 2008 | 716 | 0.220 |
Why?
|
Community-Institutional Relations | 2 | 2015 | 29 | 0.220 |
Why?
|
Patient Selection | 1 | 2007 | 682 | 0.210 |
Why?
|
Clinical Competence | 2 | 1999 | 780 | 0.210 |
Why?
|
Endocrinology | 2 | 2000 | 50 | 0.210 |
Why?
|
Community Health Workers | 1 | 2023 | 33 | 0.210 |
Why?
|
Insurance | 1 | 2022 | 12 | 0.210 |
Why?
|
Socialization | 1 | 2022 | 13 | 0.210 |
Why?
|
Rural Population | 1 | 2023 | 143 | 0.200 |
Why?
|
Problem-Based Learning | 1 | 2022 | 32 | 0.200 |
Why?
|
Advisory Committees | 1 | 2022 | 88 | 0.200 |
Why?
|
Text Messaging | 2 | 2012 | 31 | 0.200 |
Why?
|
Predictive Value of Tests | 3 | 2022 | 1715 | 0.200 |
Why?
|
Medical History Taking | 1 | 2022 | 81 | 0.200 |
Why?
|
Tape Recording | 2 | 2012 | 19 | 0.200 |
Why?
|
Regression Analysis | 4 | 2013 | 590 | 0.200 |
Why?
|
Disabled Persons | 1 | 2022 | 73 | 0.200 |
Why?
|
Health Care Rationing | 2 | 2018 | 83 | 0.200 |
Why?
|
Health Status Indicators | 1 | 2002 | 103 | 0.190 |
Why?
|
Intellectual Disability | 1 | 2022 | 189 | 0.190 |
Why?
|
Social Responsibility | 2 | 2018 | 57 | 0.190 |
Why?
|
Long-Term Care | 1 | 2021 | 61 | 0.190 |
Why?
|
Patient Outcome Assessment | 2 | 2018 | 84 | 0.190 |
Why?
|
Stereotyping | 2 | 2016 | 15 | 0.190 |
Why?
|
Diet | 4 | 2015 | 442 | 0.190 |
Why?
|
Alcoholism | 2 | 2000 | 178 | 0.190 |
Why?
|
Feasibility Studies | 5 | 2019 | 779 | 0.190 |
Why?
|
Developmental Disabilities | 1 | 2022 | 202 | 0.190 |
Why?
|
Empathy | 1 | 2022 | 150 | 0.180 |
Why?
|
Sick Role | 1 | 2000 | 13 | 0.180 |
Why?
|
Patient Advocacy | 2 | 2017 | 52 | 0.180 |
Why?
|
Financing, Organized | 1 | 2020 | 12 | 0.180 |
Why?
|
Psychiatry | 3 | 2007 | 82 | 0.180 |
Why?
|
Substance Abuse Treatment Centers | 1 | 2020 | 24 | 0.180 |
Why?
|
Gender Identity | 1 | 2020 | 53 | 0.180 |
Why?
|
Culture | 2 | 2019 | 53 | 0.180 |
Why?
|
Emergencies | 2 | 2003 | 121 | 0.180 |
Why?
|
Sickness Impact Profile | 1 | 1999 | 26 | 0.170 |
Why?
|
Population Surveillance | 2 | 2005 | 216 | 0.170 |
Why?
|
Medication Errors | 1 | 1999 | 39 | 0.170 |
Why?
|
Organizational Culture | 2 | 2016 | 32 | 0.170 |
Why?
|
Biomedical Research | 2 | 2021 | 398 | 0.170 |
Why?
|
Self-Management | 1 | 2019 | 39 | 0.170 |
Why?
|
Analysis of Variance | 3 | 2013 | 901 | 0.170 |
Why?
|
Alveolar Ridge Augmentation | 1 | 1999 | 1 | 0.170 |
Why?
|
Dental Implantation, Endosseous | 1 | 1999 | 10 | 0.170 |
Why?
|
Outpatients | 3 | 2009 | 100 | 0.170 |
Why?
|
Child, Preschool | 6 | 2019 | 3717 | 0.170 |
Why?
|
Social Class | 2 | 2016 | 135 | 0.160 |
Why?
|
Age Factors | 3 | 2015 | 1867 | 0.160 |
Why?
|
Guideline Adherence | 3 | 2008 | 229 | 0.160 |
Why?
|
Osteogenesis, Distraction | 1 | 1999 | 24 | 0.160 |
Why?
|
Dental Plaque | 1 | 1998 | 2 | 0.160 |
Why?
|
Toothbrushing | 1 | 1998 | 2 | 0.160 |
Why?
|
Dental Care for Aged | 1 | 1998 | 2 | 0.160 |
Why?
|
Artificial Intelligence | 1 | 2022 | 322 | 0.160 |
Why?
|
New Zealand | 1 | 2018 | 21 | 0.160 |
Why?
|
Blood Pressure | 6 | 2015 | 899 | 0.160 |
Why?
|
Hypoglycemic Agents | 4 | 2006 | 348 | 0.160 |
Why?
|
Albuminuria | 2 | 2016 | 48 | 0.160 |
Why?
|
Psychometrics | 2 | 2017 | 329 | 0.150 |
Why?
|
Urban Health Services | 2 | 2010 | 45 | 0.150 |
Why?
|
Local Government | 1 | 2017 | 6 | 0.150 |
Why?
|
Life Expectancy | 3 | 2008 | 89 | 0.150 |
Why?
|
Stakeholder Participation | 1 | 2018 | 22 | 0.150 |
Why?
|
Odds Ratio | 4 | 2014 | 684 | 0.150 |
Why?
|
Patient Admission | 1 | 1998 | 114 | 0.150 |
Why?
|
Linear Models | 3 | 2013 | 421 | 0.150 |
Why?
|
Transgender Persons | 1 | 2019 | 105 | 0.150 |
Why?
|
Practice Guidelines as Topic | 4 | 2008 | 1043 | 0.150 |
Why?
|
Patient Readmission | 1 | 2001 | 351 | 0.140 |
Why?
|
Fee-for-Service Plans | 1 | 2017 | 30 | 0.140 |
Why?
|
Intersectoral Collaboration | 1 | 2016 | 10 | 0.140 |
Why?
|
Financing, Personal | 1 | 2016 | 21 | 0.140 |
Why?
|
Wounds and Injuries | 1 | 1999 | 257 | 0.140 |
Why?
|
Bone Lengthening | 1 | 1996 | 4 | 0.130 |
Why?
|
Delayed Diagnosis | 1 | 2016 | 32 | 0.130 |
Why?
|
Internal Fixators | 1 | 1996 | 14 | 0.130 |
Why?
|
Micrognathism | 1 | 1996 | 11 | 0.130 |
Why?
|
Apoptosis | 1 | 2003 | 1716 | 0.130 |
Why?
|
Risk Factors | 8 | 2020 | 5466 | 0.130 |
Why?
|
Orthognathic Surgical Procedures | 1 | 1996 | 19 | 0.130 |
Why?
|
Death | 1 | 1996 | 85 | 0.130 |
Why?
|
Osteotomy | 1 | 1996 | 33 | 0.130 |
Why?
|
Retrospective Studies | 8 | 2015 | 9003 | 0.130 |
Why?
|
Substance-Related Disorders | 1 | 2020 | 414 | 0.130 |
Why?
|
Workflow | 1 | 2016 | 80 | 0.130 |
Why?
|
Asthma | 2 | 2017 | 976 | 0.130 |
Why?
|
Interpersonal Relations | 1 | 2016 | 174 | 0.130 |
Why?
|
Critical Care | 1 | 2018 | 380 | 0.130 |
Why?
|
Early Medical Intervention | 1 | 2015 | 20 | 0.130 |
Why?
|
Hospitals, University | 4 | 2001 | 195 | 0.130 |
Why?
|
Risk Assessment | 5 | 2014 | 2290 | 0.130 |
Why?
|
Length of Stay | 1 | 2018 | 732 | 0.130 |
Why?
|
Time Factors | 3 | 2019 | 5320 | 0.120 |
Why?
|
Mental Health | 3 | 2022 | 176 | 0.120 |
Why?
|
Rural Health Services | 1 | 2014 | 17 | 0.120 |
Why?
|
Nursing Methodology Research | 2 | 2007 | 11 | 0.120 |
Why?
|
Chest Pain | 1 | 1994 | 42 | 0.120 |
Why?
|
Creatinine | 1 | 2015 | 293 | 0.120 |
Why?
|
Longitudinal Studies | 3 | 2016 | 1067 | 0.120 |
Why?
|
Educational Measurement | 1 | 2016 | 231 | 0.120 |
Why?
|
Insurance, Health, Reimbursement | 3 | 2000 | 60 | 0.120 |
Why?
|
Physician Incentive Plans | 1 | 2014 | 20 | 0.120 |
Why?
|
Cell Phone | 1 | 2014 | 38 | 0.110 |
Why?
|
Statistics, Nonparametric | 1 | 2014 | 306 | 0.110 |
Why?
|
Cost Savings | 1 | 2014 | 69 | 0.110 |
Why?
|
Resource Allocation | 2 | 2008 | 65 | 0.110 |
Why?
|
Physicians, Primary Care | 1 | 2015 | 105 | 0.110 |
Why?
|
Family | 2 | 2014 | 325 | 0.110 |
Why?
|
Urea | 1 | 2013 | 59 | 0.110 |
Why?
|
Arrhythmias, Cardiac | 1 | 1994 | 197 | 0.110 |
Why?
|
Personnel Turnover | 1 | 2013 | 9 | 0.110 |
Why?
|
Disease Progression | 2 | 2015 | 1488 | 0.110 |
Why?
|
Treatment Outcome | 6 | 2014 | 8203 | 0.110 |
Why?
|
Adenoidectomy | 1 | 2012 | 23 | 0.110 |
Why?
|
Withholding Treatment | 2 | 2008 | 117 | 0.110 |
Why?
|
Financing, Government | 1 | 2012 | 24 | 0.110 |
Why?
|
Hemoglobins | 1 | 2013 | 192 | 0.100 |
Why?
|
Genetic Testing | 1 | 2016 | 537 | 0.100 |
Why?
|
Tonsillectomy | 1 | 2012 | 30 | 0.100 |
Why?
|
Melanoma | 1 | 2016 | 467 | 0.100 |
Why?
|
Internship and Residency | 1 | 2021 | 1041 | 0.100 |
Why?
|
Ambulatory Surgical Procedures | 1 | 2012 | 75 | 0.100 |
Why?
|
Career Choice | 2 | 2007 | 148 | 0.100 |
Why?
|
Diabetic Retinopathy | 3 | 2006 | 91 | 0.100 |
Why?
|
Proportional Hazards Models | 3 | 2016 | 848 | 0.100 |
Why?
|
Behavioral Risk Factor Surveillance System | 1 | 2011 | 14 | 0.100 |
Why?
|
Diagnostic Techniques, Ophthalmological | 1 | 2011 | 16 | 0.100 |
Why?
|
Mentors | 2 | 2005 | 85 | 0.100 |
Why?
|
United States Agency for Healthcare Research and Quality | 1 | 2011 | 6 | 0.100 |
Why?
|
Sympathetic Nervous System | 3 | 2000 | 94 | 0.100 |
Why?
|
Health Care Coalitions | 1 | 2011 | 9 | 0.100 |
Why?
|
Demography | 2 | 2013 | 181 | 0.090 |
Why?
|
Nephrology | 1 | 2011 | 41 | 0.090 |
Why?
|
Pain | 1 | 2013 | 400 | 0.090 |
Why?
|
Health Surveys | 2 | 2003 | 240 | 0.090 |
Why?
|
Telemedicine | 1 | 2014 | 185 | 0.090 |
Why?
|
Oregon | 3 | 2014 | 26 | 0.090 |
Why?
|
Colorado | 3 | 2014 | 37 | 0.090 |
Why?
|
Diabetic Foot | 2 | 2001 | 14 | 0.090 |
Why?
|
Suicide, Assisted | 2 | 2008 | 32 | 0.090 |
Why?
|
Frail Elderly | 2 | 2013 | 82 | 0.090 |
Why?
|
Schools | 1 | 2011 | 75 | 0.090 |
Why?
|
Pediatrics | 1 | 2014 | 352 | 0.090 |
Why?
|
Patient Protection and Affordable Care Act | 1 | 2011 | 67 | 0.090 |
Why?
|
Monte Carlo Method | 2 | 2007 | 186 | 0.090 |
Why?
|
Pain, Postoperative | 1 | 2012 | 251 | 0.090 |
Why?
|
Immunization Programs | 1 | 2009 | 24 | 0.090 |
Why?
|
Heart | 3 | 2000 | 573 | 0.090 |
Why?
|
Self Report | 1 | 2011 | 295 | 0.090 |
Why?
|
Forms and Records Control | 1 | 2009 | 16 | 0.090 |
Why?
|
Social Values | 2 | 2021 | 44 | 0.090 |
Why?
|
Lobbying | 1 | 2009 | 3 | 0.080 |
Why?
|
Nutrition Surveys | 3 | 2016 | 109 | 0.080 |
Why?
|
Environmental Pollution | 1 | 2009 | 13 | 0.080 |
Why?
|
Risk Management | 1 | 2009 | 42 | 0.080 |
Why?
|
Chronic Pain | 1 | 2011 | 162 | 0.080 |
Why?
|
Salaries and Fringe Benefits | 1 | 2009 | 22 | 0.080 |
Why?
|
Clinical Laboratory Techniques | 1 | 2009 | 76 | 0.080 |
Why?
|
Training Support | 3 | 2021 | 23 | 0.080 |
Why?
|
Schools, Medical | 1 | 2010 | 134 | 0.080 |
Why?
|
Health Resources | 2 | 2000 | 81 | 0.080 |
Why?
|
Time Management | 1 | 2008 | 9 | 0.080 |
Why?
|
Interdisciplinary Communication | 1 | 2009 | 130 | 0.080 |
Why?
|
Ethics, Clinical | 2 | 2007 | 48 | 0.080 |
Why?
|
Urban Health | 1 | 2008 | 56 | 0.080 |
Why?
|
Personnel Management | 1 | 2008 | 7 | 0.080 |
Why?
|
Blood Cells | 1 | 2008 | 33 | 0.080 |
Why?
|
Mandatory Reporting | 1 | 2007 | 7 | 0.080 |
Why?
|
Mass Screening | 3 | 2007 | 636 | 0.080 |
Why?
|
Mucopolysaccharidosis II | 1 | 2007 | 2 | 0.080 |
Why?
|
Helping Behavior | 1 | 2007 | 8 | 0.080 |
Why?
|
Medical Staff | 1 | 2007 | 10 | 0.080 |
Why?
|
Nursing Assessment | 1 | 2007 | 20 | 0.080 |
Why?
|
Nursing Staff | 1 | 2007 | 10 | 0.070 |
Why?
|
Evidence-Based Medicine | 3 | 2006 | 433 | 0.070 |
Why?
|
Pigmentation Disorders | 1 | 2007 | 13 | 0.070 |
Why?
|
Nutritional Status | 1 | 2007 | 80 | 0.070 |
Why?
|
Financial Management | 1 | 2007 | 21 | 0.070 |
Why?
|
Conscious Sedation | 1 | 2008 | 69 | 0.070 |
Why?
|
Nurse Practitioners | 1 | 2007 | 30 | 0.070 |
Why?
|
Carcinoma, Non-Small-Cell Lung | 1 | 2016 | 1114 | 0.070 |
Why?
|
Information Storage and Retrieval | 1 | 2008 | 121 | 0.070 |
Why?
|
HIV Infections | 1 | 2016 | 835 | 0.070 |
Why?
|
Refusal to Treat | 1 | 2007 | 27 | 0.070 |
Why?
|
Models, Statistical | 2 | 2007 | 575 | 0.070 |
Why?
|
Sex Factors | 4 | 2011 | 1063 | 0.070 |
Why?
|
Educational Status | 1 | 2007 | 194 | 0.070 |
Why?
|
Carotid Stenosis | 1 | 2008 | 115 | 0.070 |
Why?
|
Medically Underserved Area | 1 | 2006 | 27 | 0.070 |
Why?
|
Perception | 1 | 2008 | 178 | 0.070 |
Why?
|
Weight Loss | 2 | 2006 | 225 | 0.070 |
Why?
|
Community Participation | 2 | 2003 | 38 | 0.070 |
Why?
|
Heart Conduction System | 2 | 2000 | 112 | 0.070 |
Why?
|
Emotions | 1 | 2009 | 349 | 0.070 |
Why?
|
Canada | 2 | 2018 | 208 | 0.060 |
Why?
|
Social Behavior | 1 | 2008 | 299 | 0.060 |
Why?
|
Idaho | 2 | 2014 | 8 | 0.060 |
Why?
|
Massachusetts | 2 | 2014 | 32 | 0.060 |
Why?
|
Life Change Events | 1 | 2005 | 48 | 0.060 |
Why?
|
Dementia | 2 | 2011 | 193 | 0.060 |
Why?
|
Pennsylvania | 2 | 2014 | 94 | 0.060 |
Why?
|
Illinois | 1 | 2006 | 472 | 0.060 |
Why?
|
Insurance Claim Review | 1 | 2024 | 45 | 0.060 |
Why?
|
Texas | 1 | 2024 | 113 | 0.060 |
Why?
|
Lung Neoplasms | 1 | 2016 | 2347 | 0.060 |
Why?
|
Community Health Planning | 1 | 2003 | 21 | 0.060 |
Why?
|
Clinical Trials as Topic | 2 | 2006 | 1149 | 0.060 |
Why?
|
Professional Autonomy | 2 | 2008 | 41 | 0.060 |
Why?
|
Bone Diseases, Metabolic | 1 | 2003 | 33 | 0.050 |
Why?
|
Electrophoresis, Agar Gel | 1 | 2003 | 49 | 0.050 |
Why?
|
Organizational Case Studies | 2 | 2014 | 28 | 0.050 |
Why?
|
Image Interpretation, Computer-Assisted | 1 | 2008 | 685 | 0.050 |
Why?
|
In Situ Nick-End Labeling | 1 | 2003 | 122 | 0.050 |
Why?
|
China | 1 | 2003 | 233 | 0.050 |
Why?
|
Cell Count | 1 | 2003 | 200 | 0.050 |
Why?
|
DNA | 2 | 2003 | 1307 | 0.050 |
Why?
|
Knowledge | 1 | 2022 | 29 | 0.050 |
Why?
|
Endarterectomy, Carotid | 1 | 2003 | 75 | 0.050 |
Why?
|
Methotrexate | 1 | 2003 | 250 | 0.050 |
Why?
|
Terminal Care | 4 | 2009 | 137 | 0.050 |
Why?
|
Personal Autonomy | 2 | 2007 | 116 | 0.050 |
Why?
|
Health Maintenance Organizations | 1 | 1982 | 20 | 0.050 |
Why?
|
Bone Density | 1 | 2003 | 209 | 0.050 |
Why?
|
Universities | 2 | 2015 | 146 | 0.050 |
Why?
|
Marketing of Health Services | 1 | 1982 | 15 | 0.050 |
Why?
|
Health Benefit Plans, Employee | 1 | 1982 | 10 | 0.050 |
Why?
|
Industry | 1 | 1982 | 17 | 0.050 |
Why?
|
Hospitals, Urban | 2 | 2001 | 60 | 0.050 |
Why?
|
Health Education | 1 | 2002 | 105 | 0.050 |
Why?
|
Clinical Medicine | 1 | 2001 | 34 | 0.050 |
Why?
|
Bone Marrow Transplantation | 1 | 2002 | 283 | 0.050 |
Why?
|
Pain Measurement | 2 | 2013 | 328 | 0.050 |
Why?
|
Women's Health | 1 | 2022 | 102 | 0.050 |
Why?
|
Hospitals, Teaching | 1 | 2021 | 118 | 0.050 |
Why?
|
Coronary Artery Bypass | 1 | 2003 | 234 | 0.050 |
Why?
|
Hospitals, Veterans | 1 | 2000 | 21 | 0.050 |
Why?
|
Blood Glucose Self-Monitoring | 1 | 2001 | 54 | 0.050 |
Why?
|
Anabolic Agents | 1 | 2000 | 3 | 0.040 |
Why?
|
Incidence | 2 | 2007 | 1592 | 0.040 |
Why?
|
Follow-Up Studies | 3 | 2015 | 3657 | 0.040 |
Why?
|
Opiate Substitution Treatment | 1 | 2020 | 40 | 0.040 |
Why?
|
Peptic Ulcer | 1 | 1999 | 18 | 0.040 |
Why?
|
Photography | 1 | 2019 | 37 | 0.040 |
Why?
|
Insulin | 2 | 2006 | 1146 | 0.040 |
Why?
|
Respiratory Tract Diseases | 1 | 1999 | 45 | 0.040 |
Why?
|
Sports | 1 | 2000 | 40 | 0.040 |
Why?
|
Fibroblasts | 1 | 2003 | 755 | 0.040 |
Why?
|
Health Services | 1 | 2000 | 57 | 0.040 |
Why?
|
Computer Simulation | 1 | 2024 | 1097 | 0.040 |
Why?
|
Cause of Death | 2 | 2016 | 266 | 0.040 |
Why?
|
Accidental Falls | 1 | 1999 | 51 | 0.040 |
Why?
|
Tooth Avulsion | 1 | 1999 | 1 | 0.040 |
Why?
|
Crown Lengthening | 1 | 1999 | 1 | 0.040 |
Why?
|
Mandibular Diseases | 1 | 1999 | 16 | 0.040 |
Why?
|
Drug Interactions | 1 | 1999 | 245 | 0.040 |
Why?
|
Alveolar Bone Loss | 1 | 1999 | 20 | 0.040 |
Why?
|
Morbidity | 1 | 1999 | 149 | 0.040 |
Why?
|
Social Stigma | 1 | 2019 | 63 | 0.040 |
Why?
|
External Fixators | 1 | 1999 | 19 | 0.040 |
Why?
|
Maxilla | 1 | 1999 | 19 | 0.040 |
Why?
|
Dental Implants | 1 | 1999 | 10 | 0.040 |
Why?
|
Randomized Controlled Trials as Topic | 2 | 2019 | 833 | 0.040 |
Why?
|
Dental Plaque Index | 1 | 1998 | 3 | 0.040 |
Why?
|
Sonication | 1 | 1998 | 4 | 0.040 |
Why?
|
Dental Care for Chronically Ill | 1 | 1998 | 4 | 0.040 |
Why?
|
Survival Analysis | 2 | 2002 | 1533 | 0.040 |
Why?
|
Drug Resistance, Neoplasm | 1 | 2002 | 616 | 0.040 |
Why?
|
Hematologic Neoplasms | 1 | 2002 | 342 | 0.040 |
Why?
|
Boston | 1 | 1998 | 36 | 0.040 |
Why?
|
Grounded Theory | 1 | 2018 | 7 | 0.040 |
Why?
|
Panic Disorder | 1 | 1998 | 21 | 0.040 |
Why?
|
Sex Distribution | 1 | 1998 | 171 | 0.040 |
Why?
|
Heart Rate | 2 | 1997 | 493 | 0.040 |
Why?
|
Mandible | 1 | 1999 | 120 | 0.040 |
Why?
|
Immunosuppressive Agents | 1 | 2003 | 975 | 0.040 |
Why?
|
Persons | 1 | 1997 | 6 | 0.040 |
Why?
|
Survival Rate | 2 | 2002 | 1889 | 0.040 |
Why?
|
Ethics, Institutional | 1 | 1997 | 8 | 0.040 |
Why?
|
Congresses as Topic | 1 | 2018 | 112 | 0.040 |
Why?
|
Economic Competition | 1 | 1997 | 12 | 0.040 |
Why?
|
Electrocardiography | 3 | 1994 | 493 | 0.040 |
Why?
|
Angina Pectoris | 1 | 1997 | 28 | 0.040 |
Why?
|
Tomography, Emission-Computed, Single-Photon | 1 | 1997 | 94 | 0.040 |
Why?
|
Patient Acceptance of Health Care | 1 | 2019 | 257 | 0.040 |
Why?
|
Politics | 1 | 1997 | 52 | 0.040 |
Why?
|
Nursing Homes | 1 | 1998 | 111 | 0.040 |
Why?
|
Caregivers | 1 | 1998 | 159 | 0.040 |
Why?
|
Uncertainty | 1 | 1997 | 74 | 0.040 |
Why?
|
Organizational Policy | 1 | 1997 | 55 | 0.040 |
Why?
|
Information Dissemination | 1 | 2017 | 114 | 0.030 |
Why?
|
Cluster Analysis | 1 | 2017 | 371 | 0.030 |
Why?
|
Body Surface Potential Mapping | 1 | 1996 | 25 | 0.030 |
Why?
|
Internet | 2 | 2011 | 318 | 0.030 |
Why?
|
Respiratory Tract Infections | 1 | 1997 | 106 | 0.030 |
Why?
|
T-Lymphocytes | 1 | 2003 | 1223 | 0.030 |
Why?
|
Microstomia | 1 | 1996 | 1 | 0.030 |
Why?
|
Goldenhar Syndrome | 1 | 1996 | 2 | 0.030 |
Why?
|
Acrocephalosyndactylia | 1 | 1996 | 6 | 0.030 |
Why?
|
Marital Status | 1 | 2016 | 42 | 0.030 |
Why?
|
Receptors, Endothelin | 1 | 1995 | 12 | 0.030 |
Why?
|
Genes, jun | 1 | 1995 | 18 | 0.030 |
Why?
|
Endothelins | 1 | 1995 | 26 | 0.030 |
Why?
|
Magnetic Resonance Imaging | 1 | 2008 | 3443 | 0.030 |
Why?
|
Heart Atria | 1 | 1997 | 281 | 0.030 |
Why?
|
Tachycardia, Ventricular | 1 | 1996 | 124 | 0.030 |
Why?
|
Health Facility Size | 1 | 2015 | 9 | 0.030 |
Why?
|
Philippines | 1 | 2015 | 22 | 0.030 |
Why?
|
Catheter Ablation | 1 | 1997 | 252 | 0.030 |
Why?
|
Medical Audit | 1 | 1994 | 39 | 0.030 |
Why?
|
Risk | 1 | 1996 | 657 | 0.030 |
Why?
|
Observational Studies as Topic | 1 | 2015 | 49 | 0.030 |
Why?
|
Respiratory Sounds | 1 | 1994 | 34 | 0.030 |
Why?
|
Hospital Mortality | 1 | 1997 | 386 | 0.030 |
Why?
|
Ventricular Dysfunction, Left | 3 | 2002 | 329 | 0.030 |
Why?
|
Multicenter Studies as Topic | 1 | 1994 | 155 | 0.030 |
Why?
|
Federal Government | 1 | 2014 | 29 | 0.030 |
Why?
|
Recurrence | 1 | 1997 | 1140 | 0.030 |
Why?
|
Osteogenesis | 1 | 1996 | 255 | 0.030 |
Why?
|
Neurons, Efferent | 1 | 1993 | 5 | 0.030 |
Why?
|
Eating | 1 | 2015 | 166 | 0.030 |
Why?
|
Prognosis | 2 | 2002 | 3773 | 0.030 |
Why?
|
Cholesterol, LDL | 1 | 2015 | 223 | 0.030 |
Why?
|
Breast Neoplasms | 1 | 2007 | 3000 | 0.030 |
Why?
|
Sensitivity and Specificity | 2 | 2008 | 2014 | 0.030 |
Why?
|
California | 1 | 2013 | 144 | 0.030 |
Why?
|
Neuroblastoma | 1 | 1997 | 394 | 0.030 |
Why?
|
New South Wales | 1 | 2012 | 3 | 0.030 |
Why?
|
Vaccination | 1 | 2015 | 273 | 0.030 |
Why?
|
Atrial Fibrillation | 1 | 1997 | 350 | 0.030 |
Why?
|
Acridines | 1 | 1992 | 4 | 0.030 |
Why?
|
Alkylating Agents | 1 | 1992 | 32 | 0.030 |
Why?
|
Monitoring, Physiologic | 1 | 2014 | 266 | 0.030 |
Why?
|
Mexiletine | 1 | 1992 | 3 | 0.030 |
Why?
|
Quinidine | 1 | 1992 | 11 | 0.030 |
Why?
|
Organoplatinum Compounds | 1 | 1992 | 97 | 0.030 |
Why?
|
Prediabetic State | 1 | 2012 | 36 | 0.030 |
Why?
|
Diabetes, Gestational | 1 | 2012 | 40 | 0.030 |
Why?
|
Lidocaine | 1 | 1992 | 65 | 0.020 |
Why?
|
Thyroid Diseases | 1 | 2012 | 105 | 0.020 |
Why?
|
Swine | 3 | 1997 | 581 | 0.020 |
Why?
|
Professional Practice | 1 | 2011 | 46 | 0.020 |
Why?
|
Vitamin D Deficiency | 1 | 2012 | 103 | 0.020 |
Why?
|
Metabolic Syndrome | 1 | 2012 | 121 | 0.020 |
Why?
|
Tachycardia, Supraventricular | 1 | 1991 | 16 | 0.020 |
Why?
|
Electrocoagulation | 1 | 1991 | 23 | 0.020 |
Why?
|
Gene Expression | 1 | 1995 | 1310 | 0.020 |
Why?
|
Osteoporosis | 1 | 2012 | 122 | 0.020 |
Why?
|
Early Detection of Cancer | 1 | 2015 | 415 | 0.020 |
Why?
|
Fractures, Bone | 1 | 2012 | 127 | 0.020 |
Why?
|
Translating | 1 | 2010 | 18 | 0.020 |
Why?
|
Atrioventricular Node | 1 | 1991 | 35 | 0.020 |
Why?
|
Severity of Illness Index | 2 | 2011 | 1837 | 0.020 |
Why?
|
New York City | 1 | 2010 | 61 | 0.020 |
Why?
|
Washington | 1 | 2010 | 49 | 0.020 |
Why?
|
Eligibility Determination | 1 | 2010 | 36 | 0.020 |
Why?
|
Mineralocorticoid Receptor Antagonists | 1 | 2009 | 17 | 0.020 |
Why?
|
Hypokalemia | 1 | 2009 | 23 | 0.020 |
Why?
|
Case-Control Studies | 1 | 2014 | 1855 | 0.020 |
Why?
|
Technetium Tc 99m Sestamibi | 2 | 2000 | 15 | 0.020 |
Why?
|
Infant | 1 | 1996 | 3147 | 0.020 |
Why?
|
Diuretics | 1 | 2009 | 75 | 0.020 |
Why?
|
American Heart Association | 1 | 2009 | 94 | 0.020 |
Why?
|
Registries | 1 | 2013 | 778 | 0.020 |
Why?
|
Vasodilator Agents | 1 | 2009 | 146 | 0.020 |
Why?
|
Employee Incentive Plans | 1 | 2008 | 4 | 0.020 |
Why?
|
Personnel Loyalty | 1 | 2008 | 4 | 0.020 |
Why?
|
Right to Die | 1 | 2008 | 12 | 0.020 |
Why?
|
Interview, Psychological | 1 | 2008 | 69 | 0.020 |
Why?
|
Electrophysiology | 2 | 2000 | 403 | 0.020 |
Why?
|
Religion and Psychology | 1 | 2008 | 18 | 0.020 |
Why?
|
Sampling Studies | 1 | 2007 | 72 | 0.020 |
Why?
|
Attitude to Death | 1 | 2008 | 36 | 0.020 |
Why?
|
Staff Development | 1 | 2008 | 26 | 0.020 |
Why?
|
Cost Allocation | 1 | 2007 | 5 | 0.020 |
Why?
|
Advance Directives | 1 | 2008 | 64 | 0.020 |
Why?
|
Radiopharmaceuticals | 2 | 2000 | 193 | 0.020 |
Why?
|
Life Support Care | 1 | 2008 | 50 | 0.020 |
Why?
|
Data Interpretation, Statistical | 1 | 2009 | 299 | 0.020 |
Why?
|
Resuscitation Orders | 1 | 2008 | 63 | 0.020 |
Why?
|
Policy Making | 1 | 2007 | 62 | 0.020 |
Why?
|
Body Mass Index | 1 | 2011 | 771 | 0.020 |
Why?
|
Paternalism | 1 | 2007 | 24 | 0.020 |
Why?
|
Tomography, X-Ray Computed | 1 | 1997 | 2657 | 0.020 |
Why?
|
Siblings | 1 | 2007 | 111 | 0.020 |
Why?
|
Japan | 1 | 2007 | 303 | 0.020 |
Why?
|
Abortion, Legal | 1 | 2007 | 26 | 0.020 |
Why?
|
Stellate Ganglion | 2 | 2000 | 2 | 0.020 |
Why?
|
Workload | 1 | 2008 | 129 | 0.020 |
Why?
|
Bioethical Issues | 1 | 2007 | 38 | 0.020 |
Why?
|
Judaism | 1 | 2006 | 5 | 0.020 |
Why?
|
Protestantism | 1 | 2006 | 11 | 0.020 |
Why?
|
Animals | 8 | 2000 | 27317 | 0.020 |
Why?
|
Physician's Role | 1 | 2008 | 177 | 0.020 |
Why?
|
Diabetic Neuropathies | 1 | 2006 | 41 | 0.020 |
Why?
|
Contraception | 1 | 2007 | 92 | 0.020 |
Why?
|
Electric Stimulation | 2 | 2000 | 354 | 0.020 |
Why?
|
Diabetic Nephropathies | 1 | 2006 | 87 | 0.020 |
Why?
|
Pregnancy | 1 | 2012 | 3009 | 0.020 |
Why?
|
Cognition | 1 | 2009 | 580 | 0.020 |
Why?
|
National Institutes of Health (U.S.) | 1 | 2005 | 125 | 0.010 |
Why?
|
Image Enhancement | 1 | 2008 | 567 | 0.010 |
Why?
|
Biomarkers | 1 | 2011 | 1755 | 0.010 |
Why?
|
Electrodes | 2 | 1996 | 88 | 0.010 |
Why?
|
Mental Disorders | 1 | 2007 | 412 | 0.010 |
Why?
|
Faculty, Medical | 1 | 2005 | 185 | 0.010 |
Why?
|
Glucose Tolerance Test | 1 | 2004 | 227 | 0.010 |
Why?
|
Psychological Theory | 1 | 2002 | 22 | 0.010 |
Why?
|
Vascular Patency | 1 | 2003 | 126 | 0.010 |
Why?
|
Self Efficacy | 1 | 2002 | 54 | 0.010 |
Why?
|
In Vitro Techniques | 2 | 1995 | 996 | 0.010 |
Why?
|
Methods | 1 | 1982 | 151 | 0.010 |
Why?
|
Causality | 1 | 2002 | 80 | 0.010 |
Why?
|
Echocardiography | 2 | 1997 | 937 | 0.010 |
Why?
|
Dogs | 2 | 1993 | 704 | 0.010 |
Why?
|
Awareness | 1 | 1982 | 89 | 0.010 |
Why?
|
Ischemic Attack, Transient | 1 | 2003 | 182 | 0.010 |
Why?
|
Syndrome | 1 | 2002 | 449 | 0.010 |
Why?
|
Attitude | 1 | 1982 | 130 | 0.010 |
Why?
|
Antineoplastic Agents | 1 | 1992 | 2411 | 0.010 |
Why?
|
Statistics as Topic | 1 | 1982 | 234 | 0.010 |
Why?
|
Trinidad and Tobago | 1 | 2000 | 4 | 0.010 |
Why?
|
Sclerosing Solutions | 1 | 2000 | 5 | 0.010 |
Why?
|
Autoradiography | 1 | 2000 | 69 | 0.010 |
Why?
|
Weight Lifting | 1 | 2000 | 7 | 0.010 |
Why?
|
Denervation | 1 | 2000 | 24 | 0.010 |
Why?
|
Transplantation Conditioning | 1 | 2002 | 374 | 0.010 |
Why?
|
Phenol | 1 | 2000 | 7 | 0.010 |
Why?
|
Reoperation | 1 | 2003 | 598 | 0.010 |
Why?
|
3-Iodobenzylguanidine | 1 | 2000 | 20 | 0.010 |
Why?
|
Graft vs Host Disease | 1 | 2002 | 360 | 0.010 |
Why?
|
Transplantation, Homologous | 1 | 2002 | 995 | 0.010 |
Why?
|
Research Design | 1 | 2003 | 597 | 0.010 |
Why?
|
Norepinephrine | 1 | 2000 | 170 | 0.010 |
Why?
|
Action Potentials | 2 | 1993 | 596 | 0.010 |
Why?
|
Rabbits | 1 | 2000 | 638 | 0.010 |
Why?
|
Perfusion | 1 | 2000 | 235 | 0.010 |
Why?
|
Reference Values | 1 | 2000 | 661 | 0.010 |
Why?
|
Cognition Disorders | 1 | 1999 | 235 | 0.010 |
Why?
|
Endothelin Receptor Antagonists | 1 | 1995 | 11 | 0.010 |
Why?
|
Genes, fos | 1 | 1995 | 24 | 0.010 |
Why?
|
Peptides, Cyclic | 1 | 1995 | 44 | 0.010 |
Why?
|
Catheterization | 1 | 1996 | 237 | 0.010 |
Why?
|
Refractory Period, Electrophysiological | 1 | 1993 | 6 | 0.010 |
Why?
|
Stroke | 1 | 2003 | 982 | 0.010 |
Why?
|
Diagnosis, Differential | 1 | 1998 | 1591 | 0.010 |
Why?
|
Pericardium | 1 | 1993 | 70 | 0.010 |
Why?
|
Radionuclide Imaging | 1 | 1993 | 221 | 0.010 |
Why?
|
Hemodynamics | 1 | 1996 | 729 | 0.010 |
Why?
|
Leukemia P388 | 1 | 1992 | 3 | 0.010 |
Why?
|
Neoplasm Metastasis | 1 | 1997 | 1108 | 0.010 |
Why?
|
Drug Screening Assays, Antitumor | 1 | 1992 | 78 | 0.010 |
Why?
|
ErbB Receptors | 1 | 1995 | 500 | 0.010 |
Why?
|
Image Processing, Computer-Assisted | 1 | 1997 | 1239 | 0.010 |
Why?
|
Sodium Channels | 1 | 1992 | 129 | 0.010 |
Why?
|
Heart Block | 1 | 1991 | 31 | 0.010 |
Why?
|
Chromatography, High Pressure Liquid | 1 | 1992 | 315 | 0.010 |
Why?
|
Tumor Cells, Cultured | 1 | 1992 | 1057 | 0.010 |
Why?
|
Disease Models, Animal | 1 | 1997 | 2362 | 0.010 |
Why?
|
Cells, Cultured | 1 | 1995 | 2880 | 0.010 |
Why?
|
Kidney | 1 | 1995 | 1145 | 0.010 |
Why?
|
Cell Survival | 1 | 1992 | 982 | 0.010 |
Why?
|
Equipment Design | 1 | 1991 | 415 | 0.010 |
Why?
|
RNA, Messenger | 1 | 1995 | 2011 | 0.010 |
Why?
|
Rats | 1 | 1995 | 4040 | 0.010 |
Why?
|
Biomarkers, Tumor | 1 | 1997 | 1543 | 0.000 |
Why?
|
Signal Transduction | 1 | 1995 | 3373 | 0.000 |
Why?
|